Specific Nuclear Magnetic Resonance Lipoprotein Subclass Profiles and Central Arterial Stiffness in Type 1 Diabetes Mellitus: A Case Control Study.
arterial stiffness
cardiovascular risk
lipoprotein subclass profiles
nuclear magnetic resonance spectroscopy
preclinical atherosclerosis
type 1 diabetes mellitus
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
05 Nov 2019
05 Nov 2019
Historique:
received:
10
10
2019
revised:
02
11
2019
accepted:
04
11
2019
entrez:
8
11
2019
pubmed:
7
11
2019
medline:
7
11
2019
Statut:
epublish
Résumé
Dyslipidemia has been associated with vascular complications of type 1 diabetes mellitus (T1DM). We examined the proton nuclear magnetic resonance (NMR)-assessed lipoprotein subclass profiles in subjects with T1DM compared with those of healthy subjects and assessed the potential relationship of these profiles with arterial stiffness. Eighty-four participants with T1DM of at least 10 years duration and no clinical cardiovascular disease (age: 35-65 years; 50% men) and 42 healthy participants were evaluated for: (1) clinical and anthropometric data (including classical cardiovascular risk factors), (2) insulin sensitivity by estimated glucose disposal rate, (3) microvascular complications, (4) NMR-assessed lipoprotein subclass profile, and (5) arterial stiffness (aortic pulse wave velocity). Participants with T1DM had an apparently better conventional lipid profile than healthy participants, but with significant differences in NMR-assessed lipoprotein profiles such as higher triglyceride content of low-density lipoprotein (LDL) and high-density lipoprotein (HDL). In healthy participants, arterial stiffness was associated with NMR-based LDL subclasses. By contrast, in T1DM participants, arterial stiffness was independently associated mainly with NMR-based very-low-density lipoprotein (VLDL) subclasses: positively with total VLDL particles (and subclasses) and VLDL triglyceride content, and negatively with LDL and HDL particle sizes. These results were maintained after adjustments for classical cardiovascular risk factors. Subjects with T1DM, while having an apparently better conventional lipid profile than healthy controls, presented significant alterations in their NMR-assessed lipoprotein profile. The association between arterial stiffness and NMR-assessed lipoprotein profiles also differed in both groups. These results support a potential role of the identified differences in the residual cardiovascular risk in T1DM.
Sections du résumé
BACKGROUND
BACKGROUND
Dyslipidemia has been associated with vascular complications of type 1 diabetes mellitus (T1DM). We examined the proton nuclear magnetic resonance (NMR)-assessed lipoprotein subclass profiles in subjects with T1DM compared with those of healthy subjects and assessed the potential relationship of these profiles with arterial stiffness.
METHODS
METHODS
Eighty-four participants with T1DM of at least 10 years duration and no clinical cardiovascular disease (age: 35-65 years; 50% men) and 42 healthy participants were evaluated for: (1) clinical and anthropometric data (including classical cardiovascular risk factors), (2) insulin sensitivity by estimated glucose disposal rate, (3) microvascular complications, (4) NMR-assessed lipoprotein subclass profile, and (5) arterial stiffness (aortic pulse wave velocity).
RESULTS
RESULTS
Participants with T1DM had an apparently better conventional lipid profile than healthy participants, but with significant differences in NMR-assessed lipoprotein profiles such as higher triglyceride content of low-density lipoprotein (LDL) and high-density lipoprotein (HDL). In healthy participants, arterial stiffness was associated with NMR-based LDL subclasses. By contrast, in T1DM participants, arterial stiffness was independently associated mainly with NMR-based very-low-density lipoprotein (VLDL) subclasses: positively with total VLDL particles (and subclasses) and VLDL triglyceride content, and negatively with LDL and HDL particle sizes. These results were maintained after adjustments for classical cardiovascular risk factors.
CONCLUSIONS
CONCLUSIONS
Subjects with T1DM, while having an apparently better conventional lipid profile than healthy controls, presented significant alterations in their NMR-assessed lipoprotein profile. The association between arterial stiffness and NMR-assessed lipoprotein profiles also differed in both groups. These results support a potential role of the identified differences in the residual cardiovascular risk in T1DM.
Identifiants
pubmed: 31694246
pii: jcm8111875
doi: 10.3390/jcm8111875
pmc: PMC6912486
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI12/00954
Organisme : Instituto de Salud Carlos III
ID : PI15/00567
Organisme : Associació Catalana de Diabetis
ID : Beca Gonçal Lloveras i Vallès 2012
Références
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
Biomarkers. 2004 Mar-Apr;9(2):190-202
pubmed: 15370875
Diabetes Care. 2019 Jan;42(Suppl 1):S124-S138
pubmed: 30559237
Diabetologia. 2003 May;46(5):674-82
pubmed: 12743701
Acta Diabetol. 2012 Dec;49 Suppl 1:S253-7
pubmed: 23053880
Clin Chem. 2009 Mar;55(3):407-19
pubmed: 19168552
Int J Mol Sci. 2019 Jun 27;20(13):null
pubmed: 31252694
Atherosclerosis. 2007 May;192(1):211-7
pubmed: 16765964
Diabetes Care. 2001 Feb;24(2):250-6
pubmed: 11213874
Circulation. 2014 Oct 21;130(17):1532-58
pubmed: 25170098
Kidney Int. 2003 Sep;64(3):817-28
pubmed: 12911531
J Lipid Res. 2015 Mar;56(3):737-46
pubmed: 25568061
Eur J Clin Invest. 2001 Feb;31(2):118-24
pubmed: 11168449
Diabetes. 2000 Apr;49(4):626-32
pubmed: 10871201
Diabet Med. 2006 Sep;23(9):955-66
pubmed: 16922701
PLoS One. 2015 Aug 28;10(8):e0136348
pubmed: 26317989
Angiology. 2018 Aug;69(7):617-629
pubmed: 29172654
N Engl J Med. 2017 Apr 13;376(15):1407-1418
pubmed: 28402770
Metabolism. 2014 Feb;63(2):181-7
pubmed: 24274980
Prog Nucl Magn Reson Spectrosc. 2013 Apr;70:1-24
pubmed: 23540574
Diabetes Care. 2007 May;30(5):1248-54
pubmed: 17303788
Clin Chem. 2011 Mar;57(3):392-410
pubmed: 21266551
Atherosclerosis. 2017 Dec;267:99-109
pubmed: 29102899
Int J Clin Lab Res. 1994;24(4):187-92
pubmed: 7894041
J Diabetes Complications. 2016 May-Jun;30(4):657-68
pubmed: 26997169
Arterioscler Thromb Vasc Biol. 1996 Jun;16(6):763-72
pubmed: 8640404
Anal Bioanal Chem. 2012 Mar;402(7):2407-15
pubmed: 22293969
Diabetes. 2002 Jun;51(6):1949-56
pubmed: 12031985
J Am Coll Cardiol. 2019 Sep 3;74(9):1237-1263
pubmed: 31466622
J Hypertens. 2007 Jun;25(6):1105-87
pubmed: 17563527
J Pediatr Endocrinol Metab. 2010 Jul;23(7):661-7
pubmed: 20857838
Circ Res. 2016 Feb 19;118(4):547-63
pubmed: 26892957
Clin Chem. 2013 May;59(5):752-70
pubmed: 23386699
Diabetes. 2010 Jul;59(7):1771-9
pubmed: 20393149
J Intern Med. 2013 Apr;273(4):383-95
pubmed: 23279644
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
J Atheroscler Thromb. 2004;11(5):278-85
pubmed: 15557710
J Am Coll Cardiol. 2018 Feb 13;71(6):620-632
pubmed: 29420958
Med Sci Sports Exerc. 2004 Mar;36(3):556
pubmed: 15076800
J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27
pubmed: 20338492
Diabetes Care. 2014 Oct;37(10):2843-63
pubmed: 25114297
Diabetes Metab. 2009 Nov;35(5):353-60
pubmed: 19733492
Lancet. 2018 Aug 11;392(10146):477-486
pubmed: 30129464
N Engl J Med. 2014 Nov 20;371(21):1972-82
pubmed: 25409370
Lancet Diabetes Endocrinol. 2015 Mar;3(3):198-206
pubmed: 25660575
Atherosclerosis. 2016 Jan;244:93-100
pubmed: 26600440
Medicina (B Aires). 1995;55(4):317-23
pubmed: 8728871
Diabetes Care. 2003 May;26(5):1374-9
pubmed: 12716791
PLoS One. 2017 Apr 3;12(4):e0174640
pubmed: 28369151
Diabetes. 2016 May;65(5):1370-9
pubmed: 26895792
Diabetes Care. 2007 Mar;30(3):707-12
pubmed: 17327345
Diabetes Care. 1994 Nov;17(11):1281-9
pubmed: 7821168
Diabetes Care. 2012 May;35(5):1083-9
pubmed: 22357186
Diabetes Care. 2019 Jul;42(7):1284-1289
pubmed: 30894365
J Am Coll Cardiol. 2008 Feb 12;51(6):634-42
pubmed: 18261682
J Am Coll Cardiol. 2014 Feb 25;63(7):636-646
pubmed: 24239664
J Am Coll Cardiol. 2013 Oct 8;62(15):1309-19
pubmed: 23954339
Clin Lab Med. 2006 Dec;26(4):847-70
pubmed: 17110242
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Diabetologia. 1987 Nov;30(11):834-40
pubmed: 3328718
J Clin Invest. 2005 May;115(5):1343-51
pubmed: 15864352
Eur Heart J. 2006 Nov;27(21):2588-605
pubmed: 17000623
Nat Rev Endocrinol. 2012 Apr 10;8(8):476-85
pubmed: 22488644
Curr Opin Lipidol. 2017 Jun;28(3):261-266
pubmed: 28460374
Atherosclerosis. 2003 Apr;167(2):243-55
pubmed: 12818407
Heart. 2000 Jul;84(1):64
pubmed: 10862592